Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A17048 | 28028821 | Aliment Pharmacol Ther | Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17051 | 28027934 | Biochem Biophys Res Commun | Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. | 2016 | Details |
| A17052 | 28027788 | Atherosclerosis | Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage. | 2016 | Details |
| A17055 | 28025059 | J Hepatol | MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. | 2016 | Details |
| A17058 | 28017785 | Mol Cell Endocrinol | Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. | 2016 | Details |
| A17067 | 28011892 | Gut | Adipose type I interferon signalling protects against metabolic dysfunction. | 2016 | Details |
| A17078 | 28003715 | J Clin Exp Hepatol | High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice. | 2016 | Details |
| A17079 | 28002874 | J Gastroenterol Hepatol | High serum alanine aminotransferase is associated with the risk of colorectal adenoma in Korean men. | 2017 | Details |
| A17081 | 28001263 | Rev Assoc Med Bras (1992) | Current management of non-alcoholic fatty liver disease. | 2016 | Details |
| A17085 | 27999564 | Front Endocrinol (Lausanne) | Distinct Hepatic Macrophage Populations in Lean and Obese Mice. | 2016 | Details |
| A17089 | 27997977 | Semin Liver Dis | Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin. | 2016 | Details |
| A17096 | 27995280 | Arch Toxicol | Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A17099 | 27992443 | PLoS One | Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. | 2016 | Details |
| A17100 | 27992361 | J Pediatr Endocrinol Metab | Risk factors that affect metabolic health status in obese children. | 2017 | Details |
| A17107 | 27988872 | Drugs | Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease. | 2017 | Details |
| A17121 | 27981615 | Hepatology | Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. | 2017 | Details |
| A17129 | 27976635 | Saudi J Gastroenterol | Outcome of phlebotomy for treating nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
| A17130 | 27974597 | Nutr Rev | What is the appropriate upper limit for added sugars consumption? | 2017 | Details |
| A17133 | 27973461 | Minerva Endocrinol | Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density. | 2016 | Details |
| A17135 | 27973438 | Int J Mol Sci | Pathophysiology of Non Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17143 | 27959936 | PLoS One | A Low Dose of Dietary Quercetin Fails to Protect against the Development of an Obese Phenotype in Mice. | 2016 | Details |
| A17147 | 27957247 | World J Hepatol | Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research. | 2016 | Details |
| A17148 | 27957244 | World J Hepatol | Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease. | 2016 | Details |
| A17151 | 27956794 | World J Gastroenterol | Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. | 2016 | Details |
| A17157 | 27942596 | JCI Insight | Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. | 2016 | Details |
| A17159 | 27941355 | Curr Opin Infect Dis | Managing nonalcoholic fatty liver disease in patients living with HIV. | 2017 | Details |
| A17164 | 27938560 | Zhonghua Gan Zang Bing Za Zhi | [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats]. | 2016 | Details |
| A17173 | 27933201 | BMJ Open Gastroenterol | Association between metabolic syndrome and liver histology among NAFLD patients without diabetes. | 2016 | Details |
| A17177 | 27929200 | Thromb Haemost | Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans. | 2016 | Details |
| A17179 | 27928661 | J Bone Miner Metab | Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. | 2016 | Details |
| A17182 | 27924915 | Sci Rep | Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. | 2016 | Details |
| A17188 | 27921044 | Visc Med | Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome. | 2016 | Details |
| A17189 | 27920819 | Res Pharm Sci | Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver. | 2016 | Details |
| A17190 | 27920470 | World J Gastroenterol | Nonalcoholic fatty liver disease - A multisystem disease? | 2016 | Details |
| A17196 | 27917591 | Diabetes Obes Metab | The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism. | 2017 | Details |
| A17197 | 27917585 | Liver Int | The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease. | 2016 | Details |
| A17200 | 27916988 | Int J Obes (Lond) | Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls. | 2016 | Details |
| A17203 | 27916420 | Biomed Pharmacother | Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress. | 2016 | Details |
| A17214 | 27909908 | Recent Results Cancer Res | Obesity and Liver Cancer. | 2017 | Details |
| A17215 | 27909723 | Mol Med Rep | Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease. | 2016 | Details |
| A17217 | 27908430 | J Trace Elem Med Biol | Evaluation of tissue metal and trace element content in a rat model of non-alcoholic fatty liver disease using ICP-DRC-MS. | 2016 | Details |
| A17219 | 27907824 | J Nutr Biochem | Effect of dry tomato peel supplementation on glucose tolerance, insulin resistance, and hepatic markers in mice fed high-saturated-fat/high-cholesterol diets. | 2016 | Details |
| A17220 | 27906700 | Curr Opin Clin Nutr Metab Care | Update on lipid species and paediatric nonalcoholic fatty liver disease. | 2017 | Details |
| A17235 | 27895587 | Front Physiol | Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models. | 2016 | Details |
| A17236 | 27895422 | World J Gastroenterol | Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease. | 2016 | Details |
| A17238 | 27895393 | World J Gastroenterol | Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease. | 2016 | Details |
| A17242 | 27893763 | PLoS One | The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. | 2016 | Details |
| A17245 | 27891128 | Front Immunol | Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. | 2016 | Details |
| A17246 | 27890642 | Free Radic Biol Med | Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. | 2016 | Details |
| A17249 | 27889912 | Acta Paediatr | Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents. | 2017 | Details |
| A17255 | 27889327 | Mol Aspects Med | Epigenetics in non-alcoholic fatty liver disease. | 2016 | Details |
| A17259 | 27885258 | Sci Rep | Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects. | 2016 | Details |
| A17267 | 27879962 | Minerva Endocrinol | Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease. | 2016 | Details |
| A17273 | 27872642 | Int J Endocrinol | Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients without Overt Diabetes Evaluated by 1H-Magnetic Resonance Spectroscopy. | 2016 | Details |
| A17293 | 27860427 | J Dig Dis | The role of ADIPOQ methylation in curcumin-administrated experimental nonalcoholic fatty liver disease. | 2016 | Details |
| A17294 | 27860077 | Pathol Int | Critical in vivo roles of histamine and histamine receptor signaling in animal models of metabolic syndrome. | 2016 | Details |
| A17302 | 27856635 | J Biol Chem | MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease: A NOVEL MOUSE MODEL OF OBESITY PARADOX. | 2016 | Details |
| A17310 | 27855315 | J Nutr Biochem | Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice. | 2016 | Details |
| A17312 | 27853271 | Sci Rep | Foetal programming by methyl donor deficiency produces steato-hepatitis in rats exposed to high fat diet. | 2016 | Details |
| A17313 | 27853246 | Sci Rep | Plasma selenium levels and nonalcoholic fatty liver disease in Chinese adults: a cross-sectional analysis. | 2016 | Details |
| A17314 | 27852946 | Postgrad Med J | Non-alcoholic fatty liver disease and colorectal cancer. | 2016 | Details |
| A17315 | 27852719 | BMJ Open | Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population. | 2016 | Details |
| A17317 | 27851965 | Cell Rep | Adipose Snail1 Regulates Lipolysis and Lipid Partitioning by Suppressing Adipose Triacylglycerol Lipase Expression. | 2016 | Details |
| A17331 | 27837778 | Gastroenterol Clin North Am | Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. | 2016 | Details |
| A17348 | 27831642 | Eur Rev Med Pharmacol Sci | Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease. | 2016 | Details |
| A17351 | 27830836 | Sci Rep | Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. | 2016 | Details |
| A17354 | 27826704 | Hepatol Int | Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease. | 2016 | Details |
| A17364 | 27823604 | Endocrinol Metab Clin North Am | Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus. | 2016 | Details |
| A17372 | 27821715 | Physiol Rep | A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis. | 2016 | Details |
| A17374 | 27818933 | Mol Metab | Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. | 2016 | Details |
| A17385 | 27811231 | J Lipid Res | Genetic and hormonal control of hepatic steatosis in female and male mice. | 2016 | Details |
| A17386 | 27810989 | Diabetes Care | Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference. | 2016 | Details |
| A17391 | 27459528 | J Clin Endocrinol Metab | One-Hour Postload Hyperglycemia Confers Higher Risk of Hepatic Steatosis to HbA1c-Defined Prediabetic Subjects. | 2016 | Details |
| A17395 | 27729660 | Nat Rev Gastroenterol Hepatol | NAFLD and diabetes mellitus. | 2016 | Details |
| A17401 | 27803497 | Med Sci Monit | Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients. | 2016 | Details |
| A17402 | 27803297 | Clin Sci (Lond) | Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice. | 2016 | Details |
| A17407 | 27760050 | J Clin Invest | Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. | 2016 | Details |
| A17409 | 27797398 | Eur J Clin Invest | Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis. | 2016 | Details |
| A17418 | 27794176 | Hepatol Res | High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus. | 2016 | Details |
| A17419 | 27794174 | Mol Nutr Food Res | Polyphenol-rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high-fat diet fed rats. | 2016 | Details |
| A17421 | 27792214 | Minerva Endocrinol | Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome. | 2016 | Details |
| A17423 | 27788733 | Zhonghua Gan Zang Bing Za Zhi | [Fine particulate matter and nonalcoholic fatty liver disease]. | 2016 | Details |
| A17425 | 27788715 | Zhonghua Gan Zang Bing Za Zhi | [Autophagy and nonalcoholic fatty liver disease]. | 2016 | Details |
| A17428 | 27788707 | Zhonghua Gan Zang Bing Za Zhi | [Effect of JAZF1 over-expression on high-fat diet-induced non-alcoholic fatty liver disease]. | 2016 | Details |
| A17432 | 27710160 | Metab Syndr Relat Disord | Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans. | 2016 | Details |
| A17441 | 27785306 | Gastroenterology Res | Association of the Nonalcoholic Hepatic Steatosis and Its Degrees With the Values of Liver Enzymes and Homeostasis Model Assessment-Insulin Resistance Index. | 2015 | Details |
| A17445 | 27653239 | Hepatol Res | Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice. | 2016 | Details |
| A17448 | 26971094 | J Gastroenterol | Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17449 | 27784003 | Oncotarget | Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats. | 2016 | Details |
| A17456 | 27779710 | Mol Med Rep | Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and -10 in spontaneously hypertensive rats with steatohepatitis. | 2016 | Details |
| A17469 | 27774883 | Curr Mol Med | Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis. | 2016 | Details |
| A17478 | 27619543 | J Nutr Biochem | Cranberry extract attenuates hepatic inflammation in high-fat-fed obese mice. | 2016 | Details |
| A17480 | 27522549 | Dig Liver Dis | Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study. | 2016 | Details |
| A17481 | 27490779 | Biomed Pharmacother | Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis. | 2016 | Details |
| A17489 | 27768254 | Obesity (Silver Spring) | Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity. | 2016 | Details |
| A17491 | 27765690 | Gastroenterology | Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. | 2016 | Details |
| A17501 | 27315352 | Hepatology | Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. | 2016 | Details |
| A17509 | 27764892 | Pediatr Obes | Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease. | 2016 | Details |
| A17510 | 27764764 | Physiol Genomics | Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD. | 2016 | Details |
| A17514 | 27761469 | J Diabetes Res | Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. | 2016 | Details |